827 related articles for article (PubMed ID: 31921562)
61. Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19.
Durán-Manuel EM; Cruz-Cruz C; Ibáñez-Cervantes G; Bravata-Alcantará JC; Sosa-Hernández O; Delgado-Balbuena L; León-García G; Cortés-Ortíz IA; Cureño-Díaz MA; Castro-Escarpulli G; Vélez-Reséndiz JM; Bello-López JM
J Infect Dev Ctries; 2021 Jan; 15(1):58-68. PubMed ID: 33571146
[TBL] [Abstract][Full Text] [Related]
62. Comparison of CRISPR-Cas Immune Systems in Healthcare-Related Pathogens.
Mortensen K; Lam TJ; Ye Y
Front Microbiol; 2021; 12():758782. PubMed ID: 34759910
[TBL] [Abstract][Full Text] [Related]
63. Photodynamic therapy for ESKAPE pathogens: An emerging approach to combat antimicrobial resistance (AMR).
Mathur A; Parihar AS; Modi S; Kalra A
Microb Pathog; 2023 Oct; 183():106307. PubMed ID: 37604213
[TBL] [Abstract][Full Text] [Related]
64. Bacteremia due to ESKAPE pathogens: An emerging problem in cancer patients.
El-Mahallawy HA; Hassan SS; El-Wakil M; Moneer MM
J Egypt Natl Canc Inst; 2016 Sep; 28(3):157-62. PubMed ID: 27268592
[TBL] [Abstract][Full Text] [Related]
65. Evaluation of high-resolution melting curve analysis of ligation-mediated real-time PCR, a rapid method for epidemiological typing of ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter Species) pathogens.
Woksepp H; Ryberg A; Billström H; Hällgren A; Nilsson LE; Marklund BI; Olsson-Liljequist B; Schön T
J Clin Microbiol; 2014 Dec; 52(12):4339-42. PubMed ID: 25232168
[TBL] [Abstract][Full Text] [Related]
66. Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms.
Lee NY; Ko WC; Hsueh PR
Front Pharmacol; 2019; 10():1153. PubMed ID: 31636564
[TBL] [Abstract][Full Text] [Related]
67. Fine-Tuning of Alkaline Residues on the Hydrophilic Face Provides a Non-toxic Cationic α-Helical Antimicrobial Peptide Against Antibiotic-Resistant ESKAPE Pathogens.
Luo X; Ye X; Ding L; Zhu W; Yi P; Zhao Z; Gao H; Shu Z; Li S; Sang M; Wang J; Zhong W; Chen Z
Front Microbiol; 2021; 12():684591. PubMed ID: 34335511
[TBL] [Abstract][Full Text] [Related]
68. Epidemiology of community origin of major multidrug-resistant ESKAPE uropathogens in a paediatric population in South-East Gabon.
Mouanga-Ndzime Y; Onanga R; Longo-Pendy NM; Bignoumba M; Bisseye C
Antimicrob Resist Infect Control; 2023 May; 12(1):47. PubMed ID: 37173760
[TBL] [Abstract][Full Text] [Related]
69. High-Throughput Detection of Bacterial Community and Its Drug-Resistance Profiling From Local Reclaimed Wastewater Plants.
Limayem A; Wasson S; Mehta M; Pokhrel AR; Patil S; Nguyen M; Chen J; Nayak B
Front Cell Infect Microbiol; 2019; 9():303. PubMed ID: 31637218
[TBL] [Abstract][Full Text] [Related]
70. Antibiotic resistance of ESKAPE group-microorganisms in health institutions from Hermosillo and Ciudad Obregón, Sonora, México.
Álvarez-Ainza ML; Fong-Coronado PA; Ruiz-Bustos E; Castillón-Campaña LG; Quintero-Reyes IE; Duarte-Zambrano LA; Bolado-Martínez E
Front Cell Infect Microbiol; 2024; 14():1348093. PubMed ID: 38516533
[TBL] [Abstract][Full Text] [Related]
71. Epidemiology of Enterococcus , Staphylococcus aureus , Klebsiella , Acinetobacter , Pseudomonas , and Enterobacter Species Transmission in the Pediatric Anesthesia Work Area Environment With and Without Practitioner Use of a Personalized Body-Worn Alcohol Dispenser.
Fernandez PG; Dexter F; Brown J; Whitney G; Koff MD; Cao S; Loftus RW
Anesth Analg; 2024 Jan; 138(1):152-160. PubMed ID: 36623234
[TBL] [Abstract][Full Text] [Related]
72. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
[TBL] [Abstract][Full Text] [Related]
73. Quorum Sensing in ESKAPE Bugs: A Target for Combating Antimicrobial Resistance and Bacterial Virulence.
Santajit S; Sookrung N; Indrawattana N
Biology (Basel); 2022 Oct; 11(10):. PubMed ID: 36290370
[TBL] [Abstract][Full Text] [Related]
74. Inactivation Effect of Violet and Blue Light on ESKAPE Pathogens and Closely Related Non-pathogenic Bacterial Species - A Promising Tool Against Antibiotic-Sensitive and Antibiotic-Resistant Microorganisms.
Hoenes K; Bauer R; Meurle T; Spellerberg B; Hessling M
Front Microbiol; 2020; 11():612367. PubMed ID: 33519770
[TBL] [Abstract][Full Text] [Related]
75. Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update.
Bakhtiyari N; Farajnia S; Ghasemali S; Farajnia S; Pourmohammad A; Saeidvafa S
Infect Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38284691
[TBL] [Abstract][Full Text] [Related]
76. Genome plasticity as a paradigm of antibiotic resistance spread in ESKAPE pathogens.
Das S; Bombaywala S; Srivastava S; Kapley A; Dhodapkar R; Dafale NA
Environ Sci Pollut Res Int; 2022 Jun; 29(27):40507-40519. PubMed ID: 35349073
[TBL] [Abstract][Full Text] [Related]
77. ESKtides: a comprehensive database and mining method for ESKAPE phage-derived antimicrobial peptides.
Wu H; Chen R; Li X; Zhang Y; Zhang J; Yang Y; Wan J; Zhou Y; Chen H; Li J; Li R; Zou G
Database (Oxford); 2024 Mar; 2024():. PubMed ID: 38531599
[TBL] [Abstract][Full Text] [Related]
78. Prevalence and Phenotypic Antimicrobial Resistance among ESKAPE Bacteria and Enterobacterales Strains in Wild Birds.
Russo TP; Minichino A; Gargiulo A; Varriale L; Borrelli L; Pace A; Santaniello A; Pompameo M; Fioretti A; Dipineto L
Antibiotics (Basel); 2022 Dec; 11(12):. PubMed ID: 36551482
[TBL] [Abstract][Full Text] [Related]
79. Repositioning of Benzodiazepine Drugs and Synergistic Effect with Ciprofloxacin Against ESKAPE Pathogens.
da Rosa TF; Serafin MB; Foletto VS; Franco LN; de Paula BR; Fuchs LB; Calegari L; Hörner R
Curr Microbiol; 2023 Apr; 80(5):160. PubMed ID: 37004588
[TBL] [Abstract][Full Text] [Related]
80. The burden of hospital acquired infections and antimicrobial resistance.
Abban MK; Ayerakwa EA; Mosi L; Isawumi A
Heliyon; 2023 Oct; 9(10):e20561. PubMed ID: 37818001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
